HIGHLIGHTS
- who: Ai-Wei Feng and colleagues from the United States Vanderbilt University, United States have published the research: A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases, in the Journal: (JOURNAL) of May/16,/2020
SUMMARY
The authors had previously conducted a retrospective study at the centre, wherein a head-to-head analysis comparing HAI of FOLFOX with TOMOX for unresectable CRCLM had been performed; PFS and OS were found to be similar in both arms. For patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.